Article
Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted Therapy
27 Apr 2022
Abstract excerpt
The introduction of various targeted agents into the armamentarium of cancer treatment has revolutionized the standard care of patients with cancer. However, like conventional chemotherapy, drug resistance, either preexisting (primary or intrinsic resistance) or developed following treatment (secondary or acquired resistance), remains the Achilles heel of all targeted agents with no exception, via either genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
